BE884628A - Medicament pour la prevention de la metastase des tumeurs - Google Patents
Medicament pour la prevention de la metastase des tumeursInfo
- Publication number
- BE884628A BE884628A BE0/201645A BE201645A BE884628A BE 884628 A BE884628 A BE 884628A BE 0/201645 A BE0/201645 A BE 0/201645A BE 201645 A BE201645 A BE 201645A BE 884628 A BE884628 A BE 884628A
- Authority
- BE
- Belgium
- Prior art keywords
- medicine
- prevention
- tumor metastasis
- metastasis
- tumor
- Prior art date
Links
- 206010027476 Metastases Diseases 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- 230000009401 metastasis Effects 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19792931741 DE2931741A1 (de) | 1979-08-04 | 1979-08-04 | Arzneimittel zur vermeidung von tumormetastierung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE884628A true BE884628A (fr) | 1981-02-04 |
Family
ID=6077677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/201645A BE884628A (fr) | 1979-08-04 | 1980-08-04 | Medicament pour la prevention de la metastase des tumeurs |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS5636452A (fr) |
| AU (1) | AU539070B2 (fr) |
| BE (1) | BE884628A (fr) |
| DE (1) | DE2931741A1 (fr) |
| IT (1) | IT1212438B (fr) |
| NZ (1) | NZ194531A (fr) |
| ZA (1) | ZA804680B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2121148A1 (fr) * | 1992-08-19 | 1994-03-03 | Otsuka Pharmaceutical Co., Ltd. | Regulateur de l'apoptose |
| US5635514A (en) * | 1994-10-25 | 1997-06-03 | G. D. Searle & Company | Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as 5-lipoxgenase inhibitors |
-
1979
- 1979-08-04 DE DE19792931741 patent/DE2931741A1/de not_active Withdrawn
-
1980
- 1980-06-30 IT IT8023121A patent/IT1212438B/it active
- 1980-08-01 AU AU61006/80A patent/AU539070B2/en not_active Ceased
- 1980-08-01 NZ NZ194531A patent/NZ194531A/en unknown
- 1980-08-01 JP JP10631980A patent/JPS5636452A/ja active Pending
- 1980-08-01 ZA ZA00804680A patent/ZA804680B/xx unknown
- 1980-08-04 BE BE0/201645A patent/BE884628A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU6100680A (en) | 1981-02-12 |
| NZ194531A (en) | 1984-08-24 |
| AU539070B2 (en) | 1984-09-13 |
| JPS5636452A (en) | 1981-04-09 |
| ZA804680B (en) | 1982-04-28 |
| DE2931741A1 (de) | 1981-02-26 |
| IT8023121A0 (it) | 1980-06-30 |
| IT1212438B (it) | 1989-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE771356A (fr) | Piece d'insertion ou capsule oculaire pour application de medicaments | |
| FR2338687A1 (fr) | Endoscope pour le traitement de strictions uretrales | |
| IT1155619B (it) | Bendaggio per la somministrazione di medicamenti | |
| ES272449Y (es) | Unidad farmaceutica de administracion local. | |
| EP0402955A3 (fr) | Instrument pour administrer des produits pharmaceutiques en pastilles. | |
| IT8027029A0 (it) | Complessi platino-diamminici e formulazioni farmaceutiche per il trattamento del cancro che licontengono. | |
| OA05980A (fr) | Dispositif pour l'administration de substances médicamenteuses. | |
| FR2341315A1 (fr) | Medicaments pour le traitement des neuropathies | |
| BE850383A (fr) | Procede ameliore pour le dosage de l'alcoolemie | |
| IT1210935B (it) | Composizione farmaceutica per il trattamento di malattie cardiovascolari. | |
| BE884628A (fr) | Medicament pour la prevention de la metastase des tumeurs | |
| FR2311553A1 (fr) | Medicament pour le traitement de la schizophrenie | |
| ZA742728B (en) | Pharmaceutical composition for the treatment of coronaric ailments | |
| BE796246A (fr) | Appareil utilise pour l'accouchement des bestiaux | |
| IT8319024A0 (it) | Composizione medicinale per il trattamento di certe neurovirosi. | |
| BE860334A (fr) | Produits pour le traitement d'eaux | |
| BE886873A (fr) | Composition pharmaceutique pour combattre l'hypertension intracranienne | |
| BE860239A (fr) | Preparation medicinale pour le traitement des neoformations malignes | |
| FR2522411B1 (fr) | Etuis pour thermometre medical ou article semblable | |
| BE842389A (fr) | Composition pharmaceutique pour le traitement de l'hyperuricemie | |
| DE3382392D1 (de) | Dosierungsart zur dauerhaften verabreichung von chinidin. | |
| FR2310768A1 (fr) | Medicament pour le traitement de l'alopecia senilis | |
| IT8019228A0 (it) | Medicamento per la prevenzione ed il trattamento della cirrosi epatica. | |
| BE881640A (fr) | Nouveaux medicament pour le traitement de l'obesite | |
| BE854265A (fr) | Medicament pour le traitement d'hyperliporoteinemies primaires et secondaires |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: DR. KARL THOMAE G.M.B.H. Effective date: 19880831 |